|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.13 EUR | -0.87% |
|
-1.99% | +8.13% |
| Jan. 22 | PHILIPS NV : UBS gives a Buy rating | ZD |
| Jan. 20 | Global drugmakers rush to boost US presence as tariff threat looms | RE |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | €26.81 | +5.74% | 19 | ||||||
| $652.61 | +2.06% | 23 | ||||||
| $607.22 | +15.48% | 29 | ||||||
| $263.05 | +9.57% | 22 | ||||||
| $124.41 | +36.28% | 32 | ||||||
| €56.16 | +27.32% | 20 | ||||||
| $97.02 | +14.89% | 28 | ||||||
| $169.67 | +22.39% | 18 | ||||||
| $292.33 | +14.48% | 15 | ||||||
| $92 | +12.35% | 20 | ||||||
| CN¥278.13 | +43.74% | 21 | ||||||
| $410.01 | +2.39% | 16 | ||||||
| $133.24 | -13.46% | 17 | ||||||
| $76.92 | +2.41% | 12 | ||||||
| $116.19 | -1.33% | 16 | ||||||
| ¥2,062.31 | +9.44% | 13 | ||||||
| $54.07 | +3.76% | 14 | ||||||
| HK$10.26 | -20.49% | 3 | ||||||
| Average | 306.8 | +10.39% | 19 | ||||||
| Weighted average by Cap. | 369.53 | +13.85% | 23 |
- Stock Market
- Equities
- PHIA Stock
- Sector Philips NV
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
